|
|
|
REVIEW
Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
Over the past few years, study of the rare inherited chromosome instability disorder, Fanconi Anemia (FA), has uncovered a novel DNA damage response pathway. Through the cooperation of multiple proteins, this pathway regulates a complicated cellular response to DNA cross-linking agents and other genotoxic stresses. In this article we review recent data identifying new components of the FA pathway that implicate it in several aspects of the DNA damage response, including the direct processing of DNA, translesion synthesis, homologous recombination, and cell cycle regulation. We also discuss new findings that explain how the FA pathway is regulated through the processes of ubiquitination and deubiquitination. We then consider the clinical implications of our current understanding of the FA pathway, particularly in the development and treatment of malignancy in heterozygous carriers of FA mutations or in patients with sporadic cancers. We consider how recent studies of p53-mediated apoptosis and loss of p53 function in models of FA may help explain the clinical features of the disease and finally present a hypothesis to account for the specificity of the FA pathway in the response to DNA cross-links.
[Keywords: BRCA; cancer; chemotherapy; DNA cross-links; DNA helicase; Fanconi Anemia]
E-MAIL alan_dandrea{at}dfci.harvard.edu; FAX (617) 632-5757.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Banerjee, S. Smith, J.-H. Oum, H.-J. Liaw, J.-Y. Hwang, N. Sikdar, A. Motegi, S. E. Lee, and K. Myung Mph1p promotes gross chromosomal rearrangement through partial inhibition of homologous recombination J. Cell Biol., June 30, 2008; 181(7): 1083 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xue, Y. Li, R. Guo, C. Ling, and W. Wang FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair Hum. Mol. Genet., June 1, 2008; 17(11): 1641 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kim, Y. Kee, A. Gurtan, and A. D. D'Andrea Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24 Blood, May 15, 2008; 111(10): 5215 - 5222. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Rosenberg, B. P. Alter, and W. Ebell Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry Haematologica, April 1, 2008; 93(4): 511 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Guervilly, G. Mace-Aime, and F. Rosselli Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia Hum. Mol. Genet., March 1, 2008; 17(5): 679 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Grillari, H. Katinger, and R. Voglauer Contributions of DNA interstrand cross-links to aging of cells and organisms Nucleic Acids Res., December 14, 2007; (2007) gkm1065v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Spardy, A. Duensing, D. Charles, N. Haines, T. Nakahara, P. F. Lambert, and S. Duensing The Human Papillomavirus Type 16 E7 Oncoprotein Activates the Fanconi Anemia (FA) Pathway and Causes Accelerated Chromosomal Instability in FA Cells J. Virol., December 1, 2007; 81(23): 13265 - 13270. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nomura, N. Adachi, and H. Koyama Human Mus81 and FANCB independently contribute to repair of DNA damage during replication Genes Cells, October 1, 2007; 12(10): 1111 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gupta, S. Sharma, J. A. Sommers, M. K. Kenny, S. B. Cantor, and R. M. Brosh Jr FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein Blood, October 1, 2007; 110(7): 2390 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Couve-Privat, G. Mace, F. Rosselli, and M. K. Saparbaev Psoralen-induced DNA adducts are substrates for the base excision repair pathway in human cells Nucleic Acids Res., September 27, 2007; 35(17): 5672 - 5682. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamura, R. Ando, T. Nakazawa, T. Yudazono, N. Tsutsumi, N. Hatanaka, T. Ohgake, F. Hanaoka, and T. Eki Dicer-related drh-3 gene functions in germ-line development by maintenance of chromosomal integrity in Caenorhabditis elegans Genes Cells, September 1, 2007; 12(9): 997 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Barwell, L Pangon, S Hodgson, A Georgiou, I Kesterton, T Slade, M Taylor, S J Payne, H Brinkman, J Smythe, et al. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics J. Med. Genet., August 1, 2007; 44(8): 516 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Y. Ho, M. Parent, and M. S. Satoh Induction of Base Damages Representing a High Risk Site for Double-strand DNA Break Formation in Genomic DNA by Exposure of Cells to DNA Damaging Agents J. Biol. Chem., July 27, 2007; 282(30): 21913 - 21923. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chi, J. San Filippo, M. G. Sehorn, G. V. Petukhova, and P. Sung Bipartite stimulatory action of the Hop2-Mnd1 complex on the Rad51 recombinase Genes & Dev., July 15, 2007; 21(14): 1747 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hinz, P. B. Nham, S. S. Urbin, I. M. Jones, and L. H. Thompson Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis Nucleic Acids Res., June 28, 2007; 35(11): 3733 - 3740. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, D. P. Sejas, S. Burma, D. J. Chen, and Q. Pang Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability Carcinogenesis, June 1, 2007; 28(6): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, D. P. Sejas, Y. Qiu, D. A. Williams, and Q. Pang Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence J. Cell Sci., May 1, 2007; 120(9): 1572 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, R. D. Kennedy, K. Ray, P. Stuckert, T. Ellenberger, and A. D. D'Andrea Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway Mol. Cell. Biol., April 15, 2007; 27(8): 3098 - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Sejas, R. Rani, Y. Qiu, X. Zhang, S. R. Fagerlie, H. Nakano, D. A. Williams, and Q. Pang Inflammatory Reactive Oxygen Species-Mediated Hemopoietic Suppression in Fancc-Deficient Mice J. Immunol., April 15, 2007; 178(8): 5277 - 5287. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P Alter, P. S Rosenberg, and L. C Brody Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2 J. Med. Genet., January 1, 2007; 44(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Cantor and A. Shimamura Cellular basis of hematopoiesis and marrow failure syndromes ASH Self-Assessment Program, January 1, 2007; 2007(1): 23 - 44. [Full Text] [PDF] |
||||
![]() |
R. Gupta, S. Sharma, K. M. Doherty, J. A. Sommers, S. B. Cantor, and R. M. Brosh Jr Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand Nucleic Acids Res., December 2, 2006; 34(22): 6673 - 6683. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M.Y. Wong and K. Collins Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita Genes & Dev., October 15, 2006; 20(20): 2848 - 2858. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dokal Fanconi's anaemia and related bone marrow failure syndromes Br. Med. Bull., October 5, 2006; (2006) ldl007v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. H. Ho, S. Margossian, T. Taniguchi, and A. D. D'Andrea Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance. Mol. Cell. Biol., September 1, 2006; 26(18): 7005 - 7015. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kennedy and A. D. D'Andrea DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes J. Clin. Oncol., August 10, 2006; 24(23): 3799 - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shannon Reconsidering how we treat severe congenital neutropenia Blood, June 15, 2006; 107(12): 4575 - 4576. [Full Text] [PDF] |
||||
![]() |
S. Raynard, W. Bussen, and P. Sung A Double Holliday Junction Dissolvasome Comprising BLM, Topoisomerase III{alpha}, and BLAP75 J. Biol. Chem., May 19, 2006; 281(20): 13861 - 13864. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, L. R. Barkley, D. M. Slater, S. Tateishi, M. Yamaizumi, H. Ohmori, and C. Vaziri Rad18 Regulates DNA Polymerase {kappa} and Is Required for Recovery from S-Phase Checkpoint-Mediated Arrest. Mol. Cell. Biol., May 1, 2006; 26(9): 3527 - 3540. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. X. Zhu, A. D. D'Andrea, D. V. Sahani, and R. P. Hasserjian Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver. N. Engl. J. Med., April 27, 2006; 354(17): 1828 - 1837. [Full Text] [PDF] |
||||
![]() |
A. Shimamura Inherited Bone Marrow Failure Syndromes: Molecular Features Hematology, January 1, 2006; 2006(1): 63 - 71. [Abstract] [Full Text] [PDF] |
||||